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Glycemic load, glycemic index, and pancreatic cancer risk in the
Netherlands Cohort Study1,2
Mirjam M Heinen, Bas AJ Verhage, LH Lumey, Henny AM Brants, R Alexandra Goldbohm, and Piet A van den Brandt
ABSTRACT
Background: Recent studies of pancreatic cancer suggest a role for
hyperinsulinemia in carcinogenesis. Because insulin is secreted in
response to elevated blood glucose concentrations, dietary factors
that increase these concentrations may be important in pancreatic
carcinogenesis.
Objective: The objective was to examine prospectively the relation
between pancreatic cancer risk and dietary glycemic load (GL),
overall glycemic index (GI), and intake of total carbohydrates and
mono- and disaccharides.
Design: The Netherlands Cohort Study consisted of 120 852 men
and women who completed a baseline questionnaire in 1986. After
13.3 y of follow-up, 408 pancreatic cancer cases were detected, 66%
of which were microscopically confirmed. A validated 150-item
food-frequency questionnaire, completed at baseline, was used to
calculate carbohydrate and mono- and disaccharide intakes and the
GL and GI of the diet.
Results: Dietary GL, GI, or intake of carbohydrates and mono- and
disaccharides were not associated with pancreatic cancer risk in this
cohort. Also, the associations were not modified by sex. Our results
did not change after the analysis was restricted to microscopically
confirmed pancreatic cancer cases or after individuals who reported
a history of diabetes at baseline were excluded from the analyses.
Conclusions: Overall, our findings do not support the hypothesis
that GL, GI, or intake of carbohydrates and mono- and disaccharides
are positively associated with pancreatic cancer risk. This is in agree-
ment with previous prospective studies that investigated the relation
between GL and GI and pancreatic cancer risk. Am J Clin Nutr
2008;87:970–7.
INTRODUCTION
Pancreatic cancer is among the most rapidly fatal cancers
worldwide, with a 5-y survival rate of5% (1, 2). Few consistent
risk factors for pancreatic cancer have been identified, with cig-
arette smoking and diabetes mellitus being the most consistent
(3–5).
Evidence indicates that insulin acts as a growth promoter and
mitogen in the pancreas (6, 7). Furthermore, recent observational
studies of pancreatic cancer suggest that high insulin concentra-
tions, glucose intolerance, and insulin resistance may play a role
in carcinogenesis, even without a diagnosis of diabetes mellitus
(8–10). Type 2 diabetes seems to develop generally after pro-
longed periods of high insulin secretion rates, with a gradual
increase in insulin resistance of the liver and peripheral tissues
(10). Because insulin is secreted into the blood in response to
elevated blood glucose concentrations, dietary factors increasing
these concentrations may be associated with pancreatic cancer
risk.
The glycemic index (GI) is a measure that can be used to
quantify the postprandial glycemic effects (compared with the
glucose response of a reference food, usually white bread or
glucose) of individual foods items (11). Consumption of high-GI
diets, ie, diets in which the carbohydrates in the foods are char-
acterized by a high GI, have been shown to be associated with
hyperglycemia and hyperinsulinemia (11), whereas low-GI
meals have been shown to be associated with a lower postpran-
dial rise in glucose and insulin, probably because of a reduced
rate of glucose absorption and, therefore, a reduced postprandial
rise in insulin (11). Studies that have established GI values for
foods used portions that contain a fixed amount of carbohydrate
(generally 50 g) rather than portions that are typically consumed
(12). Hence, to estimate the total glycemic effect of the diet, the
glycemic load (GL) is calculated by using both the overall GI of
a diet as well as the actual amount of carbohydrates consumed in
the diet (13).
Studies of the influence of dietary GI and GL on pancreatic
cancer have been limited. To date, the relation between GL and
GI and pancreatic cancer risk has been examined in 4 prospective
studies (14–17). No associations have been found between GI
and GL and pancreatic cancer risk, although Michaud et al (15)
found a significantly positive association between a high GL and
pancreatic cancer incidence in women who were both sedentary
and overweight, factors that are associated with insulin resis-
tance (10).
We examined the association between pancreatic cancer risk
and dietary GL and GI, and total carbohydrate and mono- and
disaccharide intakes, in men and women within The Netherlands
Cohort Study (NLCS) on diet and cancer.
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SUBJECTS AND METHODS
Study population and follow-up of cancer
The study design of the NLCS was reported in detail elsewhere
(18). Briefly, the NLCS was initiated in September 1986 and
included 58 279 men and 62 573 women aged 55–69 y at the
beginning of the study, which originated in 204 municipalities
with computerized population registries. A self-administered
questionnaire on dietary habits, lifestyle characteristics, medical
history, and other potential risk factors for cancer was completed
at baseline. For reasons of efficiency in questionnaire processing
(which was very detailed and included open-ended question) and
follow-up, the case-cohort approach (19) was used. Case subjects
were enumerated from the entire cohort, whereas the person-
years at risk were estimated from a random sample of 5000
subjects (2411 men and 2589 women). This subcohort was se-
lected immediately after baseline and was followed-up for vital
status information. The entire cohort is being monitored for can-
cer occurrence by annual record linkage to the Netherlands Can-
cer Registry and the Netherlands Pathology Registry (20). The
follow-up was restricted to the period from baseline to December
1999, a total of 13.3 y. No subcohort members were lost to
follow-up, and completeness of the follow-up was estimated to
be96% (21).
For cases and subcohort members, all prevalent cancer cases at
baseline other than nonmelanoma skin cancer were excluded.
Additionally, subjects with incomplete and inconsistent dietary
data were also excluded from the analyses. These subjects either
1) left60 (of 150 items) questionnaire items blank and ate35
items at least once per month or 2) left one or more item blocks
(grouping of items, eg, beverages) blank. Additional details are
given elsewhere (22). Of the incident pancreatic cancer cases, all
endocrine subtypes based on histology were excluded (islet-cell
carcinomas; n  1). This resulted in a final subcohort of 4438
subjects (2191 men and 2247 women) and 408 exocrine pancre-
atic cancer cases (217 men and 191 women). Of all pancreatic
cancer cases, 66% were microscopically confirmed pancreatic
cancer (MCPC; n  269), whereas 34% were nonmicroscopi-
cally confirmed pancreatic cancer (NMCPC; n  139). The di-
agnosis of the latter group was made by the treating clinician and
was based on clinical symptoms, physical examinations, and
imaging results and was abstracted and recorded by a trained
tumor registrar (23). The NLCS was approved by the institutional
review boards of the TNO Nutrition and Food Research Institute
(Zeist, Netherlands) and Maastricht University (Maastricht,
Netherlands).
Questionnaire
The dietary section of the questionnaire was a 150-item semi-
quantitative food-frequency questionnaire (FFQ), which con-
centrated on the habitual consumption of food and beverages
during the year preceding the start of the study. Questionnaire
data were key-entered and processed for all incident cases in the
cohort and subcohort members in a standardized manner blinded
with respect to case and subcohort status. This was done to
minimize observer bias in coding and interpretation of the data.
Daily mean nutrient intakes were calculated by summing the
multiplied frequencies and portion sizes of all food items with
their tabulated nutrient contents from the Dutch food-
composition table of 1986 (24).
GI values of foods were obtained from published estimates
(13). The mean of reported GI values for a food was used if these
reported values varied across studies (13). Food items for which
a GI had not been determined were assigned the GI of the nearest
comparable food (eg, rusks, liquorice) or were calculated by
using recipes (eg, Dutch spiced cake). A GI for beer could not be
found and was estimated by using the type of carbohydrates (65%
maltose, 35% glucose). For some food items, no GI value could
be determined because of the lack of published estimates (eg,
alcohol-free beer, croquettes). For 90% of the carbohydrate
intake of each subject, a GI value was available. Lack of infor-
mation about the GI of vegetables and legumes was resolved by
calculating a mean GI for usually consumed vegetables and le-
gumes in the NLCS. In case of multiple foods per FFQ item, a GI
value was assigned to each composing food, and the GI of the
item was estimated by using the weighted average of GI values
based on carbohydrate content and prevalence of estimated pop-
ulation consumption of these foods (25). The overall dietary GI
was estimated for each participant by calculating the weighted
average GI of all food items eaten by using the carbohydrate
intake from that item (g/d) as a weighting factor. The resulting
value represents the overall quality of carbohydrate intake for
each participant. In addition, the average dietary GL was calcu-
lated by multiplying the overall dietary GI by the total amount of
carbohydrate, which was then divided by 100. Each unit of GL
represents the equivalent of 1 g carbohydrate from glucose.
The FFQ was validated and tested for reproducibility (22, 26).
Crude (and energy- and sex-adjusted) Pearson correlation coef-
ficients between the 9-d diet record and the questionnaire for total
carbohydrate and mono- and disaccharides were 0.77 (0.71) and
0.78 (0.79), respectively. For the most relevant food groups,
Spearman correlation coefficients were 0.80 for bread, 0.74 for
potatoes, and 0.84 for added sugar (22).
Statistical analysis
Dietary GL and GI and intake of total carbohydrates, mono-
and disaccharides, and fiber were all adjusted for energy intake
by the residual method (27) to enable comparison with previous
studies (14–17). Pearson correlation coefficients (r) between
energy-adjusted GL, GI, carbohydrates, and mono- and disac-
charides and food items contributing most to energy-adjusted GL
were calculated.
In the present study the overall analyses were executed on all
pancreatic cancer cases. In additional analyses we restricted the
analyses to MCPC cases to create a group with a higher degree of
diagnostic certainty of pancreatic cancer. In a previous analysis
of anthropometric measures and pancreatic cancer, a significant
positive association was observed between body mass index
(BMI) and pancreatic cancer risk among verified cases, which
was obscured when NMCPC cases were included (28).
All analyses were conducted for both sexes combined and
separately for men and women. Age-adjusted and multivariable-
adjusted incidence rate ratios, or relative risks (RRs), and corre-
sponding 95% CIs were estimated by using Cox proportional
hazards models. The total person-years at risk, estimated from
the subcohort, were used in the analyses (29). SEs were estimated
by using the robust Hubert-White sandwich estimator to account
for additional variance introduced by sampling from the cohort.
This method is equivalent to the variance-covariance estimator
presented by Barlow et al (30). The proportional hazards assump-
tion was tested by using the scaled Schoenfeld residuals (31).
GLYCEMIC LOAD AND INDEX AND PANCREATIC CANCER RISK 971
 at Universiteit M
aastricht UB Randwijck-Verwerking on January 15, 2009 
w
w
w
.ajcn.org
D
ow
nloaded from
 
RRs for energy-adjusted dietary GL and GI and intake of energy-
adjusted total carbohydrates and mono- and disaccharides were
estimated for quintiles (with the lowest quintile of intake re-
garded as the reference group) based on the sex-specific distri-
bution in the subcohort and as continuous variables. Total energy
intake (kcal/d) was included in both the age- and multivariable-
adjusted models in conformity with the method described by
Willett (27). The RRs for energy-adjusted total carbohydrates
and mono- and disaccharides can be interpreted as the effect of an
increase in these variables relative to a decrease of an equivalent
amount of energy from other energy-delivering nutrients (ie,
substituting these exposure nutrients for other energy-delivering
nutrients). Age at baseline (y), cigarette smoking (current smok-
ing: yes or no; number of cigarettes smoked per day; number of
years of smoking), BMI (kg/m2), alcohol intake (g/d), fiber in-
take (energy-adjusted; g/d), history of diabetes mellitus (yes or
no), history of hypertension (yes or no), intake of vegetables
(g/d), and intake of fruit (g/d) were included in the confounder-
adjusted models because they were associated with GL and af-
fected the RR estimates. We also considered other potential con-
founders, including level of education, nonoccupational
moderate physical activity, multivitamin use, family history of
pancreatic cancer, history of cholecystectomy, history of gall-
stones, and history of gastric ulcer, which were not included in
the final model because these variables did not change the RR
estimates. To enable comparison, age-adjusted analyses were
restricted to subjects included in multivariable-adjusted analyses
(eg, with no missing values on confounders included in the
multivariable-adjusted model). For each analysis, trends were
evaluated with the Wald test by fitting ordinal exposure variables
(quintiles of intake) as continuous terms.
As suggested by a previous study (15), we constructed com-
bined categories of BMI (cutoff: 25 kg/m2) and physical activity
(30 versus 30 min/d) resulting in 3 subgroups: a lean and
physically active group, an overweight and physically inactive
group, and an intermediate group of either lean but physically
inactive individuals or overweight but physically active individ-
uals. We stratified our analyses by these combined categories of
BMI and physical activity and, in addition, performed a formal
test for interaction by constructing multiplicative interaction
terms for each of the exposure variables and these combined
categories. Although we used quintiles of the dietary intakes in
our main analysis, for the stratified analyses we used tertiles to
avoid small case numbers. In additional analyses, individuals
who reported a history of diabetes at baseline (n  159) were
excluded. To evaluate whether early symptoms of disease before
diagnosis could have influenced the results, early cases (diag-
nosed within 2 y after baseline) were excluded in the additional
analyses. All analyses were performed by using the STATA
statistical software package (intercooled STATA, version 9;
Stata Corp, College Station. TX)). All P values were based on
2-sided tests and were considered statistically significant if
0.05.
RESULTS
Carbohydrate intake was positively correlated with GL (r 
0.96) and GI (r  0.26). Mono- and disaccharide intake was
positively correlated with GL (r  0.67), but not with GI (r 
0.02). For the 5 food groups contributing most to the GL,
correlation coefficients with GI were 0.27 for potatoes, 0.38 for
added sugar, 0.31 for bread, 0.03 for Chinese and Indonesian
foods, and 0.14 for cookies, cake, and pastry. For GL, corre-
lation coefficients were 0.27 for potatoes, 0.59 for added sugar,
0.43 for bread, 0.14 for Chinese and Indonesian foods, and 0.05
for cookies, cake, and pastry.
In Table 1, baseline characteristics (stratified by sex) are
presented. A number of characteristics did not differ between
pancreatic cancer cases and subcohort members, including age,
GL and GI of the diet, and physical activity level. However, in
men, there were more diabetics and smokers among pancreatic
cancer cases than among subcohort members. Within the pan-
creatic cancer case group, most characteristics did not differ
between total pancreatic cancer cases and MCPC cases, although
in women a history of hypertension was higher among total
pancreatic cancer cases than among MCPC cases (32.1% com-
pared with 24.8%).
No association was found when examining the association
between GL, GI, carbohydrate, mono- and disaccharide intake,
and the risk of pancreatic cancer in the total population (Table 2).
After the NMCPC cases were excluded, these findings remained.
When looking at men and women separately, no significant as-
sociations were observed for GL, GI, and carbohydrate intake
(data not shown). Among men, an inverse association was ob-
served for mono- and disaccharide intake, showing a statistically
significantly decreased risk of pancreatic cancer for the highest
versus the lowest quintile of mono- and disaccharide intake in the
multivariable-adjusted analyses (RR: 0.56; 95% CI: 0.33, 0.97; P
for trend  0.13). After the analyses were restricted to micro-
scopically verified cases, this point estimate became nonsignif-
icant (RR: 0.64; 95% CI: 0.34, 1.01). Among women, no asso-
ciation was observed for mono- and disaccharide intake. Our
findings remained the same after individuals who reported a
history of diabetes at baseline were excluded from the analyses
(325 cases left for analyses; data not shown), although the sig-
nificant decreased risk with increased mono- and disaccharide
intake observed in men became nonsignificant (multivariable-
adjusted RR: 0.59; 95% CI: 0.34, 1.02).
In additional analyses, we stratified by both BMI and physical
activity level to test whether the risk estimates were more pro-
nounced for overweight and inactive individuals. We observed
no associations in the total pancreatic cancer case group (data not
shown). When restricting the analyses to MCPC cancer cases
(Table 3), we observed no associations for GI, but observed
nonsignificantly inverse associations for GL, carbohydrate, and
mono- and disaccharide intake among physically inactive and
overweight people; among physically active and lean individu-
als, we observed nonsignificantly positive associations for these
dietary measures. In addition, individuals who reported a history
of diabetes at baseline were excluded from these analyses (218
cases left for analyses; data not shown). We observed a statisti-
cally significant 2-fold increased risk of pancreatic cancer for the
highest versus the lowest tertile of GL (P for trend0.03) among
lean and physically active individuals. Among overweight and
inactive individuals, we observed a statistically significant de-
creased pancreatic cancer risk for the highest versus the lowest
tertile of mono- and disaccharide intake with an RR of 0.31 (95%
CI: 0.10, 0.93; P for trend 0.03). However, the multiplicative
interaction terms for these stratified analyses were not statisti-
cally significant, although the interaction between mono- and
disaccharide intake and the combined categories of BMI and
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physical activity, after exclusion of diabetics, was nearly signif-
icant (P 0.06).
No associations were observed when we investigated whether
an increased consumption of high-GI food items, such as added
sugar, soft drinks, sweet sandwich spreads (eg, jam), and sweets,
were associated with a higher risk of pancreatic cancer (data not
shown). After the first 2 y of follow-up were excluded, the results
were not substantially different (data not shown).
DISCUSSION
Our results suggest that high GL and GI and a high intake of
total carbohydrates are not associated with pancreatic cancer
risk. These null findings are consistent with 4 prospective studies
(14–17) and with 5 (32–36) of 7 (32–38) previous case-control
studies that examined GL or GI and/or carbohydrate intake in
relation to pancreatic cancer risk. As regards mono- and disac-
charide intake, we found inverse associations for pancreatic can-
cer risk in men, although these became less pronounced when the
analyses were restricted to MCPC cases only.
The 1980s dietary recommendations for diabetics no longer
included low simple sugar intake (39, 40), but probably not all
diabetics and their practitioners were aware of these new guide-
lines at the time of our dietary data collection (40). Therefore, we
excluded diabetics from our analyses. The observed inverse as-
sociations between increased mono- and disaccharide intake and
pancreatic cancer risk in men became less pronounced, whereas
all other findings remained the same. Eight studies have exam-
ined the intakes of simple (monosaccharide and disaccharide)
sugars (34, 41, 42), refined sugars (35), or sucrose (14–16, 32,
42). Of these studies, just a few found an increased risk of pan-
creatic cancer (35, 41).
We also examined whether the association between high GL,
GI, and carbohydrate and mono- and disaccharide intake and the
risk of pancreatic cancer is more pronounced for subjects who are
overweight as well as inactive; we found no significant associ-
ation between GI and carbohydrate intake and pancreatic cancer
risk. When the analyses were restricted to MCPC cases without
diabetes, we observed a statistically significant decreased pan-
creatic cancer risk for mono- and disaccharide intake among
overweight and inactive individuals. Only one previous study
observed a nonsignificant inverse association between increased
mono- and disaccharide intake and pancreatic cancer risk among
male smokers (42), whereas 2 other studies (34, 41) did not
observe such an association. This finding was unexpected and
needs to be confirmed, preferably by other cohort studies.
Michaud et al (15) reported a significantly positive association
TABLE 1
Baseline characteristics of pancreatic cancer cases and subcohort members in the Netherlands Cohort Study on diet and cancer, 1986–19991
Characteristic
Men Women
Total pancreatic
cancer cases
(n 185)
Microscopically
verified
cancer cases
(n 129)
Subcohort
(n 1954)
Total pancreatic
cancer cases
(n 165)
Microscopically
verified
cancer cases
(n 105)
Subcohort
(n 2026)
Age (y) 62.1 4.0 61.7 3.8 61.2 4.2 62.1 4.2 61.1 4.3 61.4 4.3
Current smokers (%) 42.2 42.6 34.0 26.7 26.7 20.8
Years of smoking (y) 33.0 14.7 33.5 14.4 29.0 15.8 14.4 16.9 13.9 16.5 11.4 15.8
Daily intake
Energy (kcal) 2153 457 2192 442 2171 510 1713 409 1701 394 1689 395
Glycemic load (g)2 134.9 23.8 135.4 22.5 136.5 23.9 101.4 16.9 102.2 16.7 102.3 17.2
Overall glycemic index2 60.9 3.8 60.9 3.3 60.6 3.5 57.6 3.2 58.0 3.1 57.7 3.3
Total carbohydrate (g)2 223.3 37.3 223.8 35.1 226.4 37.4 176.9 27.0 176.9 25.4 178.2 26.7
Mono- and disaccharides (g)2 99.7 35.5 99.3 34.0 104.6 34.4 83.6 26.2 82.6 24.4 84.5 25.1
Total fibers (g)2 28.6 7.2 28.8 7.1 28.7 7.3 25.9 5.3 26.1 4.8 25.3 5.8
Total fat (g)2 81.6 14.1 82.3 13.9 82.5 14.1 84.9 11.4 85.0 10.5 85.3 10.3
Alcohol (g) 17.4 17.6 16.8 17.7 14.9 16.9 7.1 10.9 7.0 10.1 5.9 9.6
Vegetables (g) 195.3 94.6 199.2 99.2 192.3 83.7 212.9 83.3 215.6 81.2 196.7 81.5
Fruit (g) 148.1 119.5 140.6 106.8 156.4 115.2 197.2 109.8 193.6 100.4 197.0 120.8
Height (cm) 176.4 6.6 176.2 6.6 176.5 6.6 166.2 6.2 165.7 5.9 165.3 6.1
BMI (kg/m2) 25.3 3.0 25.6 2.7 24.9 2.6 25.6 3.6 26.1 3.8 25.0 3.5
Physical activity, nonoccupational (%)
30 min/d 14.1 16.3 17.7 24.9 25.7 22.8
30–60 min/d 35.1 31.0 30.5 30.3 31.4 31.8
60–90 min/d 24.3 23.3 19.5 24.9 21.9 23.3
90 min/d 26.5 29.5 32.4 20.0 21.0 22.2
History of diabetes (%) 9.2 7.8 3.3 4.9 5.7 3.4
History of hypertension (%) 23.8 18.6 24.2 32.1 24.8 29.0
Level of education (%)
Low 43.8 44.2 43.9 56.1 59.6 55.4
Medium 36.2 38.0 36.3 36.0 32.7 35.4
High 20.0 17.8 19.8 7.9 7.7 9.2
1 The subcohort consisted of 3980 subjects, including 17 pancreatic cancer cases.
2 Energy-adjusted intake.
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between pancreatic cancer risk and GL among obese and seden-
tary women. We were unable to reproduce this result and even
found the opposite when the analyses were restricted to MCPC
cases without diabetes. We observed a statistically significant
increased risk of pancreatic cancer among lean and physically
active individuals but no association among overweight and in-
active individuals. This might have been due to a lack of power
because of the small number of cases in the overweight and
inactive group. This result should be interpreted with caution
because this finding might have been due to chance because of
the multiple comparisons that were made in the present study.
We observed no associations between increased intake of
some high-GI foods (eg, added sugar, soft drinks, sweet sand-
wich spreads, and sweets) and pancreatic cancer risk. Very few
studies have examined these relations, and they reported no as-
sociations for jam and marmalade (43) and sweets (43), but
positive associations for soft drinks (43, 44) and added sugar
(38, 43).
So far, findings from prospective studies investigating the
relation between GL and GI and several chronic conditions, such
as type 2 diabetes, coronary heart disease, and breast and colo-
rectal cancer, have been inconsistent, showing positive (45–49)
or no (50–53) associations. Another study executed in this co-
hort, which examined the relation between GI and GL and colo-
rectal cancer risk, did not find an association (54).
Considerable evidence from in vitro, animal, and human ob-
servational studies supports a role for insulin in pancreatic cancer
etiology; therefore, the investigation of dietary factors that in-
fluence plasma insulin concentrations seems rational. The major
rationale for using GI values is based on the assumption that
postprandial blood glucose responses and insulin responses are
highly correlated, but some studies have shown an inconsistency
TABLE 2
Age-adjusted and multivariable-adjusted relative risks (RRs) and 95% CIs for pancreatic cancer according to quintile (Q) of glycemic load, overall
glycemic index, total carbohydrates, and mono- and disaccharides for men and women in the Netherlands Cohort Study on diet and cancer, 1986–19991
Nutrient
Quintile
median
Person-
years
Total pancreatic cancer cases
(n 350)
Microscopically verified cancer cases
(n 234)
Cases RR (95% CI)2 RR (95% CI)3 Cases RR (95% CI)2 RR (95% CI)3
Glycemic load (g/d)4
Q1 (low)5 88 9719 83 1.00 1.00 50 1.00 1.00
Q2 98 9775 74 0.86 (0.62, 1.21) 0.93 (0.66, 1.31) 47 0.93 (0.62, 1.41) 1.01 (0.65, 1.55)
Q3 106 9667 61 0.73 (0.52, 1.03) 0.83 (0.58, 1.18) 45 0.92 (0.61, 1.39) 1.05 (0.68, 1.62)
Q4 115 9761 73 0.86 (0.61, 1.20) 0.99 (0.69, 1.41) 51 1.03 (0.69, 1.54) 1.17 (0.76, 1.81)
Q5 (high) 156 9361 59 0.72 (0.51, 1.03) 0.85 (0.58, 1.24) 41 0.85 (0.56, 1.30) 1.00 (0.63, 1.61)
P for trend 0.099 0.558 0.646 0.731
Continuous (50-g/d intake increment) 0.87 (0.67, 1.13) 1.03 (0.77, 1.39) 0.93 (0.69, 1.25) 1.08 (0.77, 1.51)
Overall glycemic index4
Q1 (low)5 55 9772 75 1.00 1.00 43 1.00 1.00
Q2 57 9736 57 0.77 (0.54, 1.10) 0.78 (0.54, 1.12) 39 0.92 (0.59, 1.44) 0.91 (0.58, 1.44)
Q3 59 9609 76 1.05 (0.75, 1.47) 1.02 (0.72, 1.46) 48 1.15 (0.75, 1.75) 1.08 (0.69, 1.70)
Q4 61 9664 71 0.98 (0.69, 1.37) 0.94 (0.64, 1.36) 58 1.39 (0.93, 2.09) 1.30 (0.83, 2.05)
Q5 (high) 64 9502 71 1.01 (0.72, 1.42) 0.87 (0.59, 1.29) 46 1.11 (0.73, 1.71) 0.90 (0.54, 1.48)
P for trend 0.562 0.805 0.180 0.790
Continuous (5-units/d increment) 1.06 (0.89, 1.26) 0.98 (0.81, 1.19) 1.12 (0.93, 1.35) 1.00 (0.81, 1.25)
Total carbohydrate (g/d)4
Q1 (low)5 155 9808 83 1.00 1.00 50 1.00 1.00
Q2 172 9708 70 0.84 (0.60, 1.18) 0.95 (0.66, 1.35) 46 0.93 (0.61, 1.42) 1.05 (0.68, 1.62)
Q3 184 9672 68 0.82 (0.59, 1.16) 0.98 (0.68, 1.41) 49 1.01 (0.67, 1.52) 1.21 (0.76, 1.88)
Q4 199 9700 63 0.75 (0.53, 1.06) 0.94 (0.64, 1.37) 45 0.93 (0.61, 1.40) 1.16 (0.75, 1.82)
Q5 (high) 256 9394 66 0.81 (0.58, 1.14) 1.03 (0.69, 1.52) 44 0.91 (0.60, 1.38) 1.21 (0.75, 1.95)
P for trend 0.166 0.928 0.687 0.372
Continuous (50-g/d intake increment) 0.89 (0.75, 1.06) 1.04 (0.85, 1.27) 0.91 (0.76, 1.10) 1.05 (0.84, 1.31)
Mono- and disaccharides (g/d)4
Q1 (low)5 58 9756 89 1.00 1.00 59 1.00 1.00
Q2 77 9799 63 0.68 (0.49, 0.97) 0.77 (0.53, 1.10) 42 0.72 (0.48, 1.09) 0.84 (0.55, 1.29)
Q3 88 9637 67 0.75 (0.53, 1.05) 0.86 (0.60, 1.22) 50 0.88 (0.59, 1.30) 1.06 (0.70, 1.60)
Q4 103 9658 75 0.82 (0.59, 1.14) 0.99 (0.69, 1.41) 49 0.84 (0.57, 1.25) 1.09 (0.72, 1.66)
Q5 (high) 136 9432 56 0.62 (0.44, 0.89) 0.78 (0.52, 1.16) 34 0.59 (0.38, 0.91) 0.82 (0.50, 1.34)
P for trend 0.052 0.611 0.070 0.885
Continuous (50-g/d intake increment) 0.84 (0.68, 1.02) 0.96 (0.77, 1.20) 0.82 (0.65, 1.02) 0.99 (0.77, 1.26)
1 RRs and 95% CIs were calculated by using Cox proportional hazards models.
2 Adjusted for sex, age (y), and energy intake (kcal/d).
3 Adjusted for sex, age (y), energy intake (kcal/d), smoking (current smoking: yes or no; number of cigarettes smoked per day; number of years of smoking),
alcohol (g/d), history of diabetes mellitus (yes or no), history of hypertension (yes or no), BMI (kg/m2), and intake of vegetables (g/d), fruit (g/d), and fiber
(energy-adjusted; g/d).
4 Energy-adjusted intake.
5 Reference category.
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in glucose and insulin responses (12, 55). Also, whereas GI
values are determined on single food items, people eat meals or
snacks consisting not only of carbohydrates, but also of other
macronutrients. Protein stimulates insulin release, despite an
unchanged or even lower blood glucose concentration, compared
with carbohydrates alone (12). Dietary fat inhibits gastric emp-
tying, which in turn slows down the absorption of carbohydrates
(12), which also gives rise to a lower postprandial blood glucose
response. In addition, the amount of rapidly available glucose
and resistant starch, the degree of osmolality, the viscosity of the
gut’s contents, are other important factors influencing the degree
of postprandial insulin secretion (12).
The possibility to further restrict the analyses to microscopi-
cally verified cases only, where misclassification by disease sta-
tus would be less likely than among NMCPC cases (56), was one
of the strengths of this study (28). Other strengths included the
large sample size and detailed information on potential risk fac-
tors for pancreatic cancer. Differential follow-up is unlikely to
have made a material contribution to our findings, because the
completeness of follow-up was high (21). The prospective de-
sign avoided recall bias and the need to use next-of-kin respon-
dents, but nondifferential misclassification of GL values could
not be ruled out. However, because some main dietary nutrients
and food items contributing to GI and GL were in general mod-
erately to highly correlated with both the FFQ (22) and GI and
GL, the questionnaire most likely adequately ranked subjects
according to GL and GI values.
A limitation of our study was the use of a single measure of
dietary intake that may not have been representative of the di-
etary habits of the study participants over the course of follow-up.
However, the FFQ was tested for reproducibility by Goldbohm et
al (26), who concluded that a single measurement of dietary
intake in the NLCS could characterize dietary habits for a period
of at least 5 y. Our estimated GI values were lower and narrower
in range and variation than values reported in other large cohorts
(14–16, 47), which may have yielded too little contrast between
the highest and lowest quintiles to detect differences in pancre-
atic cancer risk. Another issue concerning the GI values should
TABLE 3
Multivariable-adjusted relative risks (RRs) and 95% CIs for microscopically verified pancreatic cancer according to tertile (T) of glycemic load, overall
glycemic index, total carbohydrates, and mono- and disaccharides, stratified by BMI and physical activity level in the Netherlands Cohort Study on diet
and cancer, 1986–19991
Nutrient
Tertile
median
BMI 25 kg/m2 and
moderate-to-high physical
activity2 Intermediate group3
BMI 25 kg/m2 and low
physical activity2
P for
interaction
Cases/
person-
years RR (95% CI)4
Cases/
person-
years RR (95% CI)4
Cases/
person-
years RR (95% CI)4
Glycemic load (g/d)5
T1 (low)6 94 21/7289 1.00 44/7244 1.00 9/1544 1.00
T2 108 29/6772 1.86 (1.02, 3.38) 46/7403 1.14 (0.73, 1.79) 10/1895 0.76 (0.30, 1.94)
T3 (high) 146 30/7662 1.84 (0.96, 3.52) 37/6561 0.99 (0.60, 1.63) 8/1409 0.70 (0.27, 1.81)
P for trend 0.066 0.975 0.465 0.650
Continuous (50-g/d intake increment) 1.40 (0.84, 2.33) 0.95 (0.58, 1.54) 0.50 (0.16, 1.58)
Overall glycemic index5
T1 (low)6 56 30/7559 1.00 34/7028 1.00 5/1542 1.00
T2 59 25/7340 0.91 (0.51, 1.62) 38/7223 0.98 (0.58, 1.65) 12/1265 2.93 (0.85, 10.09)
T3 (high) 63 25/6824 0.91 (0.51, 1.63) 55/6957 1.33 (0.75, 2.37) 10/2040 1.02 (0.21, 4.88)
P for trend 0.742 0.295 0.882 0.398
Continuous (5-units/d increment) 0.89 (0.67, 1.19) 1.10 (0.78, 1.55) 0.81 (0.45, 1.47)
Total carbohydrate (g/d)5
T1 (low)6 164 23/7044 1.00 51/7516 1.00 9/1615 1.00
T2 189 30/6827 1.65 (0.91, 2.97) 44/7285 1.00 (0.66, 1.53) 10/1774 0.78 (0.32, 1.92)
T3 (high) 243 27/7852 1.39 (0.72, 2.69) 32/6407 0.81 (0.50, 1.33) 8/1459 0.71 (0.29, 1.72)
P for trend 0.337 0.415 0.453 0.616
Continuous (50-g/d intake increment) 1.33 (0.94, 1.88) 0.93 (0.68, 1.28) 0.61 (0.30, 1.24)
Mono- and disaccharides (g/d)5
T1 (low)6 66 18/7105 1.00 50/7261 1.00 14/1859 1.00
T2 91 32/7041 2.00 (1.02, 3.91) 44/7235 1.11 (0.71, 1.74) 8/1566 0.60 (0.25, 1.45)
T3 (high) 123 30/7578 1.92 (0.93, 3.93) 33/6711 0.96 (0.58, 1.60) 5/1423 0.39 (0.14, 1.12)
P for trend 0.076 0.936 0.066 0.082
Continuous (50-g/d intake increment) 1.43 (0.97, 2.10) 0.82 (0.59, 1.13) 0.47 (0.21, 1.02)
1 RRs and 95% CIs were calculated by using Cox proportional hazards models.
2 Moderate-to-high physical activity level30 min/d; low physical activity level30 min/d.
3 Intermediate group either BMI 25 with moderate-to-high physical activity or BMI 25 with low physical activity.
4 Adjusted for sex, age (y), energy intake (kcal/d), smoking (current smoking: yes or no; number of cigarettes smoked per day; number of years of smoking),
alcohol (g/d), history of diabetes mellitus (yes or no), history of hypertension (yes or no), and intake of vegetables (g/d), fruit (g/d), and fiber (energy-adjusted;
g/d).
5 Energy-adjusted intake.
6 Reference category.
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be mentioned. The GI values used for this FFQ were obtained
from the table published by Foster-Powell et al (13), as has been
used by others. However, this GI table contains mostly items
from Australian or American foods and not from European
foods. Recently, Henry et al (57) established GI values for a
variety of foods available in the United Kingdom, which con-
cluded that most GI values compared well with previously pub-
lished values (13); however, a few values were notably different
from those of Foster-Powell et al (13). It remains to be estab-
lished whether values determined for American and Australian
food items can be applied to European foods.
In summary, our findings do not support the hypothesis that a
high GL, overall GI, and carbohydrate and mono- and disaccha-
ride intake are associated with an increased risk of pancreatic
cancer. This finding agrees with previous prospective studies
that investigated the relation between GL and GI and pancreatic
cancer risk.
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